Four Hours is Enough for Lactation Interruption After High-Dose Methylprednisolone Treatment in Multiple Sclerosis Mothers by Measuring Milk Cortisol Levels

Gündüz, Suzan; Gençler, Onur Serdar; Çelik, Hüseyin

doi:10.3109/14767058.2015.1135120

Cited by 2 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Transfer of high doses of IV CS into the breast milk is very low (about 1% of the maternal amount). 133,134 The peak is observed 1 hour after the infusion. The half-life in the breast milk is 2 hours; there is, therefore, no accumulation in case of repeated administration over several days.…”

Section: Resultsmentioning

confidence: 98%

Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society

Vukusic

Ciron²,

Maillart

et al. 2022

Mult Scler

View full text Add to dashboard Cite

Objective: The objective of this study was to develop evidence-based recommendations on pregnancy management for persons with multiple sclerosis (MS). Background: MS typically affects young women in their childbearing years. Increasing evidence is available to inform questions raised by MS patients and health professionals about pregnancy issues. Methods: The French Group for Recommendations in Multiple Sclerosis (France4MS) reviewed PubMed and university databases (January 1975 through June 2021). The RAND/UCLA appropriateness method was developed to synthesise the scientific literature and expert opinions on healthcare topics; it was used to reach a formal agreement. Fifty-six MS experts worked on the full-text review and initial wording of recommendations. A group of 62 multidisciplinary healthcare specialists validated the final proposal of summarised evidence. Results: A strong agreement was reached for all 104 proposed recommendations. They cover diverse topics, such as pregnancy planning, follow-up during pregnancy and postpartum, delivery routes, locoregional analgesia or anaesthesia, prevention of postpartum relapses, breastfeeding, vaccinations, reproductive assistance, management of relapses and disease-modifying treatments. Conclusion: The 2022 recommendations of the French MS society should be helpful to harmonise counselling and treatment practice for pregnancy in persons with MS, allowing for better and individualised choices.

show abstract

Section: Resultsmentioning

confidence: 98%

Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society

Vukusic

Ciron²,

Maillart

et al. 2022

Mult Scler

View full text Add to dashboard Cite

show abstract

“…Transfer of high doses of IV CS into the breastmilk is very low (about 1% of the maternal amount). 55,56 The peak is observed 1 hour after the infusion. The half-life of the breastmilk is 2 hours; there is, therefore, no accumulation in case of repeated administration over several days.…”

Section: Resultsmentioning

confidence: 98%

Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society

et al. 2022

View full text Add to dashboard Cite

Background: In 2020, the French Multiple Sclerosis (MS) Society (SFSEP) decided to develop a national evidence-based consensus on pregnancy in MS. As neuromyelitis optica spectrum disorders (NMOSD) shares a series of commonalities with MS, but also some significant differences, specific recommendations had to be developed. Objectives: To establish recommendations on pregnancy in women with NMOSD. Methods: The French Group for Recommendations in Multiple Sclerosis (France4MS) reviewed PubMed and universities databases (January 1975 through June 2021). The RAND/UCLA appropriateness method, which was developed to synthesise the scientific literature and expert opinions on health care topics, was used to reach a formal agreement. Fifty-six MS experts worked on the full-text review and initial wording of recommendations. A sub-group of nine NMOSD experts was dedicated to analysing available data on NMOSD. A group of 62 multidisciplinary healthcare specialists validated the final proposal of summarised evidence. Results: A strong agreement was reached for all 66 proposed recommendations. They cover diverse topics, such as pregnancy planning, follow-up during pregnancy and postpartum, delivery routes, loco-regional analgesia or anaesthesia, prevention of postpartum relapses, breastfeeding, vaccinations, reproductive assistance, management of relapses, and disease-modifying treatments. Conclusion: Physicians and patients should be aware of the new and specific evidence-based recommendations of the French MS Society for pregnancy in women with NMOSD. They should help harmonise counselling and treatment practise, allowing for better individualised choices.

show abstract

Four Hours is Enough for Lactation Interruption After High-Dose Methylprednisolone Treatment in Multiple Sclerosis Mothers by Measuring Milk Cortisol Levels

Cited by 2 publications

References 3 publications

Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society

Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society

Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society

Contact Info

Product

Resources

About